Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Pain Assessment in Children With Cerebral Palsy Through Parasympathetic Tone Analysis.

NCT: NCT02364856 · COMPLETED

NCT IDNCT02364856
StatusCOMPLETED
Start Date2015-04-24
Completion2018-04-12

Brief Summary

This study evaluates Analgesia Nociception Index (Heart Rate Variability based index) and its variations after painful stimulations in children with cerebral palsy : acute procedural pain (botulinum toxin injections), and recurrent pain (physiotherapy).

Frequently Asked Questions

What is Pain Assessment in Children With Cerebral Palsy Through Parasympathetic Tone Analysis.?

Pain Assessment in Children With Cerebral Palsy Through Parasympathetic Tone Analysis. is a clinical trial registered under NCT02364856. Current status: COMPLETED.

What is the status of NCT02364856?

The current status of NCT02364856 (Pain Assessment in Children With Cerebral Palsy Through Parasympathetic Tone Analysis.) is: COMPLETED.

When did Pain Assessment in Children With Cerebral Palsy Through Parasympathetic Tone Analysis. start?

Pain Assessment in Children With Cerebral Palsy Through Parasympathetic Tone Analysis. started on 2015-04-24.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑